Substance / Medication

Ibandronate

Overview

Active Ingredient
ibandronate
RxNorm CUI
115264

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Ibandronate in the Prevention of Vertebral and Nonvertebral Osteoporotic Fractures: A Systematic Review of Experimental and Observational Studies.
Mendes Diogo, Penedones Ana, Alves Carlos et al. · J Clin Rheumatol · 2023
PMID: 36731043Meta-Analysis
Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta-analysis.
Mitsuboshi Satoru, Kotake Kazumasa · Pharmacotherapy · 2022
PMID: 35716279Meta-Analysis
Does Local Ibandronate and/or Pamidronate Delivery Enhance Osseointegration? A Systematic Review.
Kellesarian Sergio Varela, Abduljabbar Tariq, Vohra Fahim et al. · J Prosthodont · 2018
PMID: 27870311Meta-Analysis
Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis.
Ma Zeren, Li Yong, Zhou Ming et al. · PLoS One · 2016
PMID: 26930292Meta-AnalysisFull text (PMC)
Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis.
Hou Yanjie, Gu Ke, Xu Chao et al. · Medicine (Baltimore) · 2015
PMID: 26131800Meta-AnalysisFull text (PMC)
Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.
Miller P D, Recker R R, Harris S et al. · Osteoporos Int · 2014
PMID: 24136103Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ibandronate (substance)
SNOMED CT
96287002
UMLS CUI
C0379199
RxNorm CUI
115264

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.